Annual report pursuant to Section 13 and 15(d)

Unaudited Quarterly Data (Tables)

v3.20.1
Unaudited Quarterly Data (Tables)
12 Months Ended
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Data on Financial Information

    Three months ended  
($ in thousands, except per share data)   March 31, 2018
(As Restated)
    June 30, 2018
(As Restated)
    September 30, 2018
(As Restated)
    December 31, 2018  
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
Revenue   $ 90,453     $ 83,525     $ 88,837     $ 121,940  
Gross profit   $ 12,230     $ 13,076     $ 18,696     $ 8,885  
Operating loss   $ (149 )   $ (2,358 )   $ (12,264 )   $ (23,522 )
Net (loss) income   $ (1,087 )   $ 7,501     $ (12,987 )   $ (40,019 )
Cumulative preferred dividends   $ (20 )   $ (20 )   $ (20 )   $ (20 )
Net (loss) income applicable to common shares   $ (1,107 )   $ 7,481     $ (13,007 )   $ (40,039 )
Net (loss) income per common share – basic   $ (0.19 )   $ 1.13     $ (1.68 )   $ (3.79 )
Net (loss) income per common share – diluted   $ (0.19 )   $ 0.50     $ (1.68 )   $ (3.79 )
Weighted average number of common shares outstanding – basic     5,851,288       6,601,685       7,745,537       10,577,376  
Weighted average number of common shares outstanding – diluted     5,851,288       14,996,607       7,745,537       10,577,376  

 

    Three months ended  
($ in thousands, except per share data)   March 31, 2017
(As Restated)
    June 30, 2017
(As Restated)
    September 30, 2017
(As Restated)
    December 31, 2017
(As Restated)
 
    (unaudited)     (unaudited)     (unaudited)     (unaudited)  
Revenue   $ 5,443     $ 42,581     $ 96,827     $ 70,658  
Gross profit (loss)   $ 2,750     $ 9,255     $ 23,776     $ (5,424 )
Operating (loss) income   $ (2,658 )   $ 220     $ 14,161     $ (22,185 )
Net loss   $ (12,351 )   $ (34,524 )   $ (1,748 )   $ (43,460 )
Cumulative preferred dividends   $ (20 )   $ (20 )   $ (20 )   $ (20 )
Net loss applicable to common shares   $ (12,371 )   $ (34,544 )   $ (1,768 )   $ (43,480 )
Net loss per common share – basic and diluted   $ (3.73 )   $ (7.22 )   $ (0.33 )   $ (7.83 )
Weighted average number of common shares outstanding – basic and diluted     3,312,373       4,787,556       5,367,966       5,552,429  

 

Explanatory Note:

 

The Company is providing restated quarterly and year-to-date unaudited consolidated financial information for interim periods occurring within years ended December 31, 2018 and 2017 in order to comply with SEC requirements. See Note 2 for further background concerning the events preceding the restatement of financial information in this Form 10-K.

 

As discussed in Note 2, the Audit Committee and the Company identified certain errors that are corrected through adjustments made as part of the restatement. These adjustments include corrections related to the investigation of convertible notes that was conducted, as well as (i) corrections related to the Company’s convertible notes and (ii) corrections resulting from management’s review of significant accounts and transactions.

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended March 31, 2018 is as follows:

 

    As of March 31, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 9,638     $ 24     $ 9,662  
Accounts receivable, net     78,251       (17,166 )     61,085  
Costs and estimated earnings in excess of billings on uncompleted contracts     4,552       (1,107 )     3,445  
Other current assets     9,782       (273 )     9,509  
Total current assets     102,223       (18,522 )     83,701  
                         
Property and equipment, net     8,121       (1,466 )     6,655  
Intangible assets, net     25,443             25,443  
Goodwill     35,672       9,335       45,007  
Total assets     171,459       (10,653 )     160,806  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current Liabilities:                        
Accounts payable     46,095       (366 )     45,729  
Billings in excess of costs and estimated earnings on uncompleted contracts     18,516       8,588       27,104  
Due to related party     28             28  
Accrued expenses and other current liabilities     7,259       282       7,541  
Senior notes payable, current portion net of original discount and deferred financing costs           25,807       25,807  
Convertible notes payable, net of original issue discount and deferred financing cost           3,548       3,548  
Merchant credit agreements, net of original issue discount and deferred financing cost           2,369       2,369  
Notes payable, current portion, net of original issue discount and deferred financing costs     10,182       (6,910 )     3,272  
Notes payable, related parties, current portion     7,603             7,603  
Debt derivative liability           22,077       22,077  
Warrant liability           29,897       29,897  
Total current liabilities     89,683       85,292       174,975  
                         
Notes payable, non-current portion     1,934       (125 )     1,809  
Notes payable, related parties, non-current net of debt discount     39,523             39,523  
Senior note payable, non-current portion, net of original issue discount and deferred financing costs     26,408       (26,408 )      
Deferred tax liability     1,122       (39 )     1,083  
Total liabilities     158,670       58,720       217,390  
                         
Commitments and contingencies                        
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at March 31, 2018                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at March 31, 2018                  
Series G convertible preferred stock, $0.001 stated value, 1,780 shares designated and 1,780 shares issued and outstanding at March 31, 2018                  
Common stock, $0.001 par value, 100,000,000 shares authorized 6,136,059 shares issued and outstanding at March 31, 2018, respectively     6             6  
Additional paid-in capital     57,792       8,436       66,228  
Shares to be issued     6,681       (375 )     6,306  
Subscriptions receivable     (3,222 )     3,222        
Accumulated deficit     (48,468 )     (80,656 )     (129,124 )
Total stockholders’ deficit     12,789       (69,373 )     (56,584 )
Total liabilities and stockholders’ deficit     171,459       (10,653 )     160,806  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended March 31, 2018 is as follows:

 

    Three Months ended March 31, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
                   
Revenues, net of discounts   $ 85,145     $ 5,308     $ 90,453  
Cost of revenues     73,654       4,569       78,223  
Gross profit     11,491       739       12,230  
                         
Operating expenses                        
Compensation expense     5,638       224       5,862  
Selling, general and administrative expenses     4,639       907       5,546  
Amortization expense     938             938  
Loss on sale of asset     33             33  
Transaction expenses     93       (93 )      
Total operating expenses     11,341       1,038       12,379  
Operating income (loss)     150       (299 )     (149 )
                         
Other (expenses) income                        
Interest expense     (913 )     (122 )     (1,035 )
Amortization of deferred financing costs and debt discount     (5,912 )     (2,215 )     (8,127 )
Gain on debt derivative liability           11,759       11,759  
Loss on warrant liability           (13,821 )     (13,821 )
Other (expense) income, net     (597 )     (190 )     (787 )
Extinguishment loss     (322 )     14,823       14,501  
Loss on issuance of notes           (2,860 )     (2,860 )
Financing costs     (2,002 )     2,002        
Total other expenses, net     (9,746 )     9,376       (370 )
Loss before provision for income taxes     (9,596 )     9,077       (519 )
Provision for income taxes     568             568  
                         
Net loss     (10,164 )     9,077       (1,087 )
Preferred stock dividends     (20 )           (20 )
Net loss attributable to common shareholders   $ (10,184 )   $ 9,077     $ (1,107 )
                         
Loss per common share:                        
Basic and diluted   $ (2.09 )   $ 1.55     $ (0.19 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     4,876,131       5,851,288       5,851,288  

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended June 30, 2018 is as follows:

 

    As of June 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 12,884     $ 2     $ 12,886  
Accounts receivable, net     72,693       (12,779 )     59,914  
Costs and estimated earnings in excess of billings on uncompleted contract     2,206       1,023       3,229  
Other current assets     8,814       (1,796 )     7,018  
Total current assets     96,597       (13,550 )     83,047  
                         
Property and equipment, net     9,165       (2,367 )     6,798  
Intangible assets, net     23,190             23,190  
Goodwill     35,672       9,335       45,007  
Total assets     164,624       (6,582 )     158,042  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current Liabilities:                        
Accounts payable     40,175       (477 )     39,698  
Billings in excess of costs and estimated earnings on uncompleted contracts     21,754       10,498       32,252  
Due to related parties     89             89  
Accrued expenses and other current liabilities     7,141       1,651       8,792  
Convertible notes payable, net of original issue discount and deferred financing cost           4,591       4,591  
Merchant credit agreements, net of original issue discount and deferred financing cost           2,668       2,668  
Senior notes payable, current portion, net of original issue discount and deferred financing costs     28,661       (451 )     28,210  
Notes payable and capital leases, current portion, net of original issue discount and deferred financing costs     14,343       (11,466 )     2,877  
Notes payable, related party     19,173       (850 )     18,323  
Debt derivative liability           8,416       8,416  
Warrant liability           26,793       26,793  
Total current liabilities     131,336       41,373       172,709  
                         
Notes payable, non-current portion     1,617             1,617  
Notes payable, non-current portion, related parties net of debt discount     27,775             27,775  
Deferred tax liability     1,007             1,007  
Total liabilities     161,735       41,373       203,108  
                         
Commitments and contingencies                        
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at June 30, 2018                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at June 30, 2018                  
Series G convertible preferred stock, $0.001 stated value, 1,780 shares designated and 1,780 shares issued and outstanding at June 30, 2018                  
Common stock, $0.001 par value, 100,000,000 shares authorized and 7,225,158 shares issued and outstanding at June 30, 2018     7             7  
Additional paid-in capital     67,677       8,876       76,553  
Subscriptions receivable     (2,769 )     2,769        
Accumulated deficit     (62,026 )     (59,600 )     (121,626 )
Total stockholders’ (deficit) equity     2,889       (47,955 )     (45,066 )
Total liabilities and stockholders’ (deficit) equity   $ 164,624     $ (6,582 )   $ 158,042  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended June 30, 2018 is as follows:

 

    Three Months ended June 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 86,367     $ (2,842 )   $ 83,525  
Cost of revenues     72,415       (1,966 )     70,449  
Gross profit     13,952       (876 )     13,076  
                         
Operating expenses                        
Compensation expense     6,856       757       7,613  
Selling, general and administrative expenses     5,855       1,075       6,930  
Amortization of intangible assets     938             938  
Loss on sale of asset     (47 )           (47 )
Transaction expenses     33       (33 )      
Total operating expenses     13,635       1,799       15,434  
Operating income (loss)     317       (2,675 )     (2,358 )
                         
Other (expenses) income                        
Interest expense     (2,889 )     (71 )     (2,960 )
Amortization of deferred financing costs and debt discount     (3,458 )     (3,685 )     (7,143 )
Gain on debt derivative liability           6,313       6,313  
Gain on warrant liability           2,748       2,748  
Other income, net     (1,421 )     2,191       770  
Loss on issuance of notes           (1,591 )     (1,591 )
Gain on extinguishment of debt           11,607       11,607  
Financing costs     (6,214 )     6,214        
Total other (expenses) income, net     (13,982 )     23,726       9,744  
(Loss) income before provision for income taxes     (13,665 )     21,051       7,386  
(Benefit) for income taxes     (107 )     (8 )     (115 )
                         
Net (loss) income     (13,558 )     21,059       7,501  
Preferred stock dividends     (20 )           (20 )
Net (loss) income attributable to common shareholders   $ (13,578 )   $ 21,059     $ 7,481  
                         
(Loss) income per common share:                        
Basic   $ (2.26 )   $ 3.19     $ 1.13  
Diluted   $ (2.26   $ 1.40     $ 0.50  
                         
Weighted average number of common shares outstanding                        
Basic     5,997,856       6,601,685       6,601,685  
Diluted     5,997,856       14,996,607       14,996,607  

 

The effect of the restatement on the previously filed consolidated statement of operations for the six months ended June 30, 2018 is as follows:

 

    Six Months ended June 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 171,511     $ 2,467     $ 173,978  
Cost of revenues     146,069       2,603       148,672  
Gross profit     25,442       (136 )     25,306  
                         
Operating expenses                        
Compensation expense     12,494       981       13,475  
Selling, general and administrative expenses     10,494       1,982       12,476  
Amortization of intangible assets     1,876             1,876  
Loss on sale of asset     (13 )     (1 )     (14 )
Transaction expenses     125       (125 )      
Total operating expenses     24,976       2,837       27,813  
Operating loss     466       (2,973 )     (2,507 )
                         
Other (expenses) income                        
Interest expense     (3,802 )     (193 )     (3,995 )
Amortization of deferred financing costs and debt discount     (9,370 )     (5,900 )     (15,270 )
Gain on conversion derivative liability           18,072       18,072  
Loss on warrant derivative liability           (11,073 )     (11,073 )
Other expense, net     (1,744 )     1,727       (17 )
Loss on issuance of debt           (4,451 )     (4,451 )
Extinguishment gain           26,108       26,108  
Financing costs     (8,812 )     8,812        
Total other expenses, net     (23,728 )     33,102       9,374  
Loss before provision for income taxes     (23,262 )     30,129       6,867  
Provision for income taxes     460       (7 )     453  
                         
Net loss     (23,722 )     30,136       6,414  
Preferred stock dividends     (40 )           (40 )
Net loss attributable to common shareholders   $ (23,762 )   $ 30,136     $ 6,374  
                         
Loss per common share:                        
Basic   $ (4.53 )   $ 4.84     $ 1.02  
Diluted   $ (4.53 )   $ 2.06     $ 0.44  
                         
Weighted average number of common shares outstanding                        
Basic     5,249,808       6,228,559       6,228,559  
Diluted     5,249,808       14,632,985       14,632,985  

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended September 30, 2018 is as follows:

 

    As of September 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 5,722     $ 2     $ 5,724  
Accounts receivable, net     75,812       (10,179 )     65,633  
Costs and estimated earnings in excess of billings on uncompleted contract     4,362       (1,434 )     2,928  
Other current assets     6,416       (173 )     6,243  
Total current assets     92,312       (11,784 )     80,528  
                         
Property and equipment, net     9,956       (3,353 )     6,603  
Intangible assets, net     20,937             20,937  
Goodwill     35,672       9,335       45,007  
Total assets     158,877       (5,802 )     153,075  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current liabilities:                        
Accounts payable     29,307       (389 )     28,918  
Billings in excess of costs and estimated earnings on uncompleted contracts     27,984       7,881       35,865  
Due to related parties     56             56  
Accrued expenses and other current liabilities     9,160       778       9,938  
Senior notes payable, current, net of original issue discount and deferred financing costs     31,122       (264 )     30,858  
Convertible notes payable, net of original issue discount and deferred financing cost           8,186       8,186  
Merchant credit agreements, net of original issue discount and deferred financing cost           4,821       4,821  
Notes payable and capital leases, current portion, net of original issue discount and deferred financing costs     17,474       (14,347 )     3,127  
Notes payable, current portion, related parties     18,334             18,334  
Debt derivative liability           11,885       11,885  
Warrant liability           11,522       11,522  
Total current liabilities     133,437       30,073       163,510  
                         
Notes payable, non-current portion     1,414             1,414  
Notes payable, non-current portion, related parties net of debt discount     28,463             28,463  
Deferred tax liability     1,128       513       1,641  
Total liabilities     164,442       30,586       195,028  
                         
Commitments and contingencies                        
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at September 30, 2018                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at September 30, 2018                  
Common stock, $0.001 par value, 100,000,000 shares authorized and 8,605,021 shares issued and outstanding at September 30, 2018     8             8  
Additional paid-in capital     71,421       21,231       92,652  
Shares to be issued                  
Subscriptions receivable     (2,941 )     2,941        
Accumulated deficit     (74,053 )     (60,560 )     (134,613 )
Total stockholders’ (deficit) equity     (5,565 )     (36,388 )     (41,953 )
Total liabilities and stockholders’ (deficit) equity   $ 158,877     $ (5,802 )   $ 153,075  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2018 is as follows:

 

    Three Months ended September 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 92,224     $ (3,387 )   $ 88,837  
Cost of revenues     76,311       (6,170 )     70,141  
Gross profit     15,913       2,783       18,696  
                         
Operating expenses                        
Compensation expense     9,283       11,038       20,321  
Selling, general and administrative expenses     9,045       656       9,701  
Amortization of intangible assets     938             938  
Transaction expenses                  
Total operating expenses     19,266       11,694       30,960  
Operating loss     (3,353 )     (8,911 )     (12,264 )
                         
Other (expenses) income                        
Interest expense     (2,140 )     (74 )     (2,214 )
Amortization of deferred financing costs and debt discount     (4,318 )     (4,059 )     (8,377 )
(Loss) on debt derivative liability           (2,627 )     (2,627 )
Gain on warrant liability           14,787       14,787  
Other (expense) income, net     (572 )     602       30  
Loss on issuance of notes           (203 )     (203 )
Extinguishment loss           (1,485 )     (1,485 )
Financing costs     (1,374 )     1,374        
Total other (expenses) income, net     (8,404 )     8,315       (89 )
Loss before provision for income taxes     (11,757 )     (596 )     (12,353 )
Provision for income taxes     268       366       634  
                         
Net loss     (12,025 )     (962 )     (12,987 )
Preferred stock dividends     (20 )           (20 )
Net loss attributable to common shareholders   $ (12,045 )   $ (962 )   $ (13,007 )
                         
Income per common share:                        
Basic and diluted   $ (1.89 )   $ (0.12 )   $ (1.68 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     6,372,775       7,745,537       7,745,537  

 

The effect of the restatement on the previously filed consolidated statement of operations for the nine months ended September 30, 2018 is as follows:

 

    Nine Months ended September 30, 2018  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 263,735     $ (920 )   $ 262,815  
Cost of revenues     222,380       (3,567 )     218,813  
Gross profit     41,355       2,647       44,002  
                         
Operating expenses                        
Compensation expense -selling general and administrative     21,777       12,019       33,796  
Selling, general and administrative expenses     19,653       2,524       22,177  
Amortization of intangible assets     2,813       1       2,814  
Loss on sale of asset           (14 )     (14 )
Transaction expenses                  
Total operating expenses     44,243       14,530       58,773  
Operating loss     (2,888 )     (11,883 )     (14,771 )
                         
Other expenses                        
Interest expense     (5,942 )     (267 )     (6,209 )
Amortization of deferred financing costs and debt discount     (13,688 )     (9,959 )     (23,647 )
Gain on debt derivative liability           15,445       15,445  
Gain on warrant liability           3,714       3,714  
Other (expense) income, net     (2,316 )     2,329       13  
Loss on issuance of notes           (4,654 )     (4,654 )
Extinguishment gain           24,623       24,623  
Financing costs     (10,187 )     10,187        
Total other expenses, net     (32,133 )     41,418       9,285  
Loss before provision for income taxes     (35,021 )     29,535       (5,486 )
Provision for income taxes     728       359       1,087  
                         
Net loss     (35,749 )     29,176       (6,573 )
Preferred stock dividends     (60 )           (60 )
Net loss attributable to common shareholders   $ (35,809 )   $ 29,176     $ (6,633 )
                         
Loss per common share:                        
Basic and diluted   $ (6.36 )   $ 4.33     $ (0.98 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     5,630,556       6,739,775       6,739,775  

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended March 31, 2017 is as follows:

 

    As of March 31, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 2     $     $ 2  
Accounts receivable, net     9,985       (5,446 )     4,539  
Other current assets     3,649       (1,443 )     2,206  
Total current assets     13,636       (6,889 )     6,747  
                         
Property and equipment, net     4,300       (25 )     4,275  
Total assets     17,936       (6,914 )     11,022  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current Liabilities:                        
Accounts payable     2,332       (148 )     2,184  
Due to related party     190       (35 )     155  
Accrued expenses and other current liabilities     3,508       784       4,292  
Convertible notes payable, net of original issue discount and deferred financing cost           175       175  
Merchant credit agreements, net of original issue discount and deferred financing cost           36       36  
Notes payable, current portion, net of original issue discount and deferred financing costs     5,431       3,754       9,185  
Notes payable, related parties, current portion     791       35       826  
Debt derivative liability           2,773       2,773  
Warrant liability     3,357       5,060       8,417  
Total current liabilities     15,609       12,434       28,043  
                         
Notes payable, non-current portion     7,300       (5,171 )     2,129  
Senior note payable, non-current portion, net of original issue discount and deferred financing costs     5,082       (1,113 )     3,969  
Total liabilities     27,991       6,150       34,141  
                         
Commitments and contingencies                        
                         
Temporary equity:                        
Common stock; $0.001 par value, subject to put provision, 100,000,000 shares authorized and 444,275 shares issued and outstanding at March 31, 2017     437             437  
Total temporary equity     437             437  
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at March 31, 2017                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at March 31, 2017                  
Common stock, $0.001 par value, 100,000,000 shares authorized 3,536,096 shares issued and outstanding at March 31, 2017     88       (85 )     3  
Additional paid-in capital     17,484       6,648       24,132  
Shares to be issued     615             615  
Subscriptions receivable     (5,658 )     5,658        
Accumulated deficit     (23,021 )     (25,285 )     (48,306 )
Total stockholders’ deficit     (10,492 )     (13,064 )     (23,556 )
Total liabilities and stockholders’ deficit   $ 17,936     $ (6,914 )   $ 11,022  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended March 31, 2017 is as follows:

 

    Three Months ended March 31, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 5,086     $ 357     $ 5,443  
Cost of revenues     2,678       15       2,693  
Gross profit     2,408       342       2,750  
                         
Operating expenses                        
Compensation expense     1,187       3,040       4,227  
Selling, general and administrative expenses     1,187       (198 )     989  
Loss on sale of asset           (8 )     (8 )
Transaction expenses     11       189       200  
Total operating expenses     2,385       3,023       5,408  
Operating income (loss)     23       (2,681 )     (2,658 )
                         
Other (expenses) income                        
Interest expense     (734 )     (123 )     (857 )
Amortization of deferred financing costs and debt discount     (397 )     (857 )     (1,254 )
Gain on debt derivative liability           97       97  
Loss on warrant liability     (2,200 )     (2,450 )     (4,650 )
Other (expense) income, net     (100 )     156       56  
Loss on issuance of notes           (3,085 )     (3,085 )
Financing costs     (563 )     563        
Total other expenses, net     (3,994 )     (5,699 )     (9,693 )
Loss before provision for income taxes     (3,971 )     (8,380 )     (12,351 )
Provision for income taxes                  
                         
Net loss     (3,971 )     (8,380 )     (12,351 )
Preferred stock dividends     (20 )           (20 )
Net loss attributable to common shareholders   $ (3,991 )   $ (8,380 )   $ (12,371 )
                         
Loss per common share:             .          
Basic and diluted   $ (1.09 )   $ (2.53 )   $ (3.73 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     3,677,614       3,312,373       3,312,373  

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended June 30, 2017 is as follows:

 

    As of June 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 7,835     $     $ 7,835  
Accounts receivable, net     36,707       (1,705 )     35,002  
Costs and estimated earnings in excess of billings on uncompleted contract     5,966       (1,313 )     4,653  
Other current assets     6,736       (1,224 )     5,512  
Total current assets     57,244       (4,242 )     53,002  
                         
Property and equipment, net     5,556       (106 )     5,450  
Intangible assets, net     29,320             29,320  
Goodwill     46,922       9,790       56,712  
Total assets     139,042       5,442       144,484  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current Liabilities:                        
Accounts payable     22,255       4,005       26,260  
Billings in excess of costs and estimated earnings on uncompleted contracts     15,380       7,209       22,589  
Due to related parties     154       (43 )     111  
Accrued expenses and other current liabilities     6,609       750       7,359  
Convertible notes payable, net of original issue discount and deferred financing cost           813       813  
Merchant credit agreement, net of original issue discount and deferred financing cost           57       57  
Notes payable and capital leases, current portion, net of original issue discount and deferred financing costs     12,012       (7,753 )     4,259  
Notes payable, current portion, related party     791       7,293       8,084  
Debt derivative liability           13,467       13,467  
Warrant liability     2,336       24,874       27,210  
Total current liabilities     59,537       50,672       110,209  
                         
Notes payable, non-current portion     46,981       (44,959 )     2,022  
Notes payable, non-current portion, related party           42,500       42,500  
Senior note payable, non-current portion, net of original issue discount and deferred financing costs     19,951       (238 )     19,713  
Total liabilities     126,469       47,975       174,444  
                         
Commitments and contingencies                        
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at June 30, 2017                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at June 30, 2017                  
Common stock, $0.001 par value, 100,000,000 shares authorized and 5,208,185 shares issued and outstanding at June 30, 2017     130       (115 )     15  
Additional paid-in capital     43,011       7,104       50,115  
Shares to be issued     2,201       550       2,751  
Subscriptions receivable     (4,656 )     4,656        
Accumulated deficit     (28,113 )     (54,728 )     (82,841 )
Total stockholders’ (deficit) equity     12,573       (42,533 )     (29,960 )
Total liabilities and stockholders’ (deficit) equity   $ 139,042     $ 5,442     $ 144,484  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended June 30, 2017 is as follows:

 

    Three Months ended June 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 50,697     $ (8,116 )   $ 42,581  
Cost of revenues     42,377       (9,051 )     33,326  
Gross profit     8,320       935       9,255  
                         
Operating expenses                        
Compensation expense     4,169       380       4,549  
Selling, general and administrative expenses     4,000       14       4,014  
Amortization of intangible assets     589             589  
Loss on sale of asset     429       (801 )     (372 )
Transaction expenses     1,409       (1,154 )     255  
Total operating expenses     10,596       (1,561 )     9,035  
Operating (loss) income     (2,276 )     2,496       220  
                         
Other (expenses) income                        
Interest expense     (1,793 )     (131 )     (1,924 )
Amortization of deferred financing costs and debt discount     (1,934 )     (1,743 )     (3,677 )
Gain on debt derivative liability           498       498  
Gain (loss) on warrant liability     1,021       (8,684 )     (7,663 )
Other income, net     10       (1,390 )     (1,380 )
Loss on issuance of notes           (23,350 )     (23,350 )
Extinguishment gain           2,873       2,873  
Total other expenses, net     (2,696 )     (31,927 )     (34,623 )
Loss before provision for income taxes     (4,972 )     (29,431 )     (34,403 )
Provision for income taxes     121             121  
                         
Net loss     (5,093 )     (29,431 )     (34,524 )
Preferred stock dividends     (20 )           (20 )
Net loss attributable to common shareholders   $ (5,113 )   $ (29,431 )   $ (34,544 )
                         
Loss per common share:             .          
Basic and diluted   $ (1.02 )   $ (6.15 )   $ (7.22 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     4,989,451       4,787,556       4,787,556  

 

The effect of the restatement on the previously filed consolidated statement of operations for the six months ended June 30, 2017 is as follows:

 

    Six Months ended June 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 55,783     $ (7,759 )   $ 48,024  
Cost of revenues     45,055       (9,036 )     36,019  
Gross profit     10,728       1,277       12,005  
                         
Operating expenses                        
Compensation expense     5,356       3,420       8,776  
Selling, general and administrative expenses     5,188       (185 )     5,003  
Amortization of intangible assets     589             589  
Loss on sale of asset     472       (852 )     (380 )
Transaction expenses     1,419       (964 )     455  
Total operating expenses     13,024       1,419       14,443  
Operating loss     (2,296 )     (142 )     (2,438 )
                         
Other (expenses) income                        
Interest expense     (2,527 )     (254 )     (2,781 )
Amortization of deferred financing costs and debt discount     (2,331 )     (2,600 )     (4,931 )
Gain on conversion derivative liability           595       595  
Loss on warrant derivative liability     (1,179 )     (11,134 )     (12,313 )
Other expense, net     (46 )     (1,278 )     (1,324 )
Loss on issuance of notes           (23,350 )     (23,350 )
Extinguishment loss           (212 )     (212 )
Financing costs     (563 )     563        
Total other expenses, net     (6,646 )     (37,670 )     (44,316 )
Loss before provision for income taxes     (8,942 )     (37,812 )     (46,754 )
Provision for income taxes     121             121  
                         
Net loss     (9,063 )     (38,812 )     (46,875 )
Preferred stock dividends     (40 )           (40 )
Net loss attributable to common shareholders   $ (9,103 )   $ (38,812 )   $ (46,915 )
                         
Loss per common share:                        
Basic and diluted   $ (2.11 )   $ (9.33 )   $ (11.57 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     4,305,814       4,054,039       4,054,039  

 

The effect of the restatement on the previously filed consolidated balance sheet for the period ended September 30, 2017 is as follows:

 

    As of September 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
ASSETS                        
Current Assets:                        
Cash and cash equivalents   $ 3,154     $     $ 3,154  
Accounts receivable, net     51,791       212       52,003  
Costs and estimated earnings in excess of billings on uncompleted contract     6,773       1,035       7,808  
Other current assets     7,727       (1,270 )     6,457  
Total current assets     69,445       (23 )     69,422  
                         
Property and equipment, net     7,101       (130 )     6,971  
Intangible assets, net     26,306             26,306  
Goodwill     46,922       9,790       56,712  
Total assets     149,774       9,637       159,411  
                         
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)                        
Current liabilities:                        
Accounts payable     33,531       6,103       39,634  
Billings in excess of costs and estimated earnings on uncompleted contracts     7,378       512       7,890  
Due to related parties     343       (254 )     89  
Accrued expenses and other current liabilities     9,931       704       10,635  
Convertible notes payable, net of original issue discount and deferred financing cost           1,818       1,818  
Merchant credit agreement, net of original issue discount and deferred financing cost           482       482  
Notes payable and capital leases, current portion, net of original issue discount and deferred financing costs     14,022       (9,713 )     4,309  
Notes payable, current portion, related parties     791       5,087       5,878  
Debt derivative liability           36,482       36,482  
Warrant liability     303       14,543       14,846  
Total current liabilities     66,299       55,764       122,063  
                         
Notes payable, non-current portion     46,899       (45,013 )     1,886  
Notes payable, non-current portion, related party           42,500       42,500  
Senior note payable, non-current portion, net of original issue discount and deferred financing costs     20,022       3,539       23,561  
Total liabilities     133,220       56,790       190,010  
                         
Commitments and contingencies                        
                         
Stockholders’ Equity (Deficit):                        
Preferred stock; $0.01 par value, 5,000,000 shares authorized:                  
Series A convertible preferred stock, $1,000 stated value, 4,500 shares designated and 500 shares issued and outstanding at September 30, 2017                  
Series A-1 convertible preferred stock, $1,000 stated value, 1,000 shares designated and 295 shares issued and outstanding at September 30, 2017                  
Common stock, $0.001 par value, 100,000,000 shares authorized and 5,435,083 shares issued and outstanding at September 30, 2017     5             5  
Additional paid-in capital     45,625       8,101       53,726  
Shares to be issued     75       175       250  
Subscriptions receivable     (3,588 )     3,588        
Accumulated deficit     (25,563 )     (59,017 )     (84,580 )
Total stockholders’ (deficit) equity     16,554       (47,153 )     (30,599 )
Total liabilities and stockholders’ (deficit) equity   $ 149,774     $ 9,637     $ 159,411  

 

The effect of the restatement on the previously filed consolidated statement of operations for the three months ended September 30, 2017 is as follows:

 

    Three Months ended September 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 79,083     $ 17,744     $ 96,827  
Cost of revenues     63,553       9,498       73,051  
Gross profit     15,530       8,246       23,776  
                         
Operating expenses                        
Compensation expense     5,312       716       6,028  
Selling, general and administrative expenses     4,414       (1,605 )     2,809  
Amortization of intangible assets     768             768  
Gain on sale of assets           (236 )     (236 )
Transaction expenses     246             246  
Total operating expenses     10,740       (1,125 )     9,615  
Operating income     4,790       9,371       14,161  
                         
Other (expenses) income                        
Interest expense     (1,824 )     (82 )     (1,906 )
Amortization of deferred financing costs and debt discount     (1,332 )     (1,569 )     (2,901 )
Loss on debt derivative liability           (22,133 )     (22,133 )
Gain on warrant liability     2,033       10,398       12,431  
Other (expense) income, net     (7 )     301       294  
Loss on issuance of notes           (911 )     (911 )
Extinguishment gain           190       190  
Financing costs     (139 )     139        
Total other expenses, net     (1,269 )     (13,667 )     (14,936 )
Loss before provision for income taxes     3,521       (4,296 )     (775 )
Provision for income taxes     972       1       973  
                         
Net loss     2,549       (4,297 )     (1,748 )
Preferred stock dividends     (20 )           (20 )
Net loss attributable to common shareholders   $ 2,529     $ (4,297 )   $ (1,768 )
                         
Loss per common share:                        
Basic and diluted   $ 0.47     $ (0.80 )   $ (0.33 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     5,367,208       5,367,966       5,367,966  

 

The effect of the restatement on the previously filed consolidated statement of operations for the nine months ended September 30, 2017 is as follows:

 

    Nine Months ended September 30, 2017  
($ in thousands, except per share data)   As Previously Reported     Adjustments     As Restated  
    (unaudited)     (unaudited)     (unaudited)  
Revenues, net of discounts   $ 134,866     $ 9,985     $ 144,851  
Cost of revenues     108,608       462       109,070  
Gross profit     26,258       9,523       35,781  
                         
Operating expenses                        
Compensation expense -selling general and administrative     10,668       4,136       14,804  
Selling, general and administrative expenses     9,696       (1,884 )     7,812  
Amortization of intangible assets     1,358             1,358  
Loss on sale of asset     376       (992 )     (616 )
Transaction expenses     1,666       (965 )     701  
Total operating expenses     23,764       295       24,059  
Operating loss     2,494       9,228       11,722  
                         
Other expenses                        
Interest expense     (4,351 )     (335 )     (4,686 )
Amortization of deferred financing costs and debt discount     (3,663 )     (4,169 )     (7,832 )
Loss on debt derivative liability           (21,539 )     (21,539 )
Gain (loss) on warrant liability     854       (736 )     118  
Other (expense) income, net     (52 )     (977 )     (1,029 )
Loss on issuance of notes           (24,262 )     (24,262 )
Extinguishment loss           (21 )     (21 )
Financing costs     (702 )     702        
Total other expenses, net     (7,914 )     (51,337 )     (59,251 )
Loss before provision for income taxes     (5,420 )     (42,109 )     (47,529 )
Provision for income taxes     1,093       1       1,094  
                         
Net loss     (6,513 )     (42,110 )     (48,623 )
Preferred stock dividends     (60 )           (60 )
Net loss attributable to common shareholders   $ (6,573 )   $ (42,110 )   $ (48,683 )
                         
Loss per common share:                        
Basic and diluted   $ (1.40 )   $ (9.36 )   $ (10.83 )
                         
Weighted average number of common shares outstanding                        
Basic and diluted     4,699,369       4,496,828       4,496,828